Re-modelling 'hostile' milieu of diseased myocardium via paracrine function of transplanted cells or relaxin: Commentary

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 5, 2007, Pages 1101-1104

  Du, Xiao Jun ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Angiogenesis; Cell therapy; Extracellular matrix; Fibrosis; Myoblasts; Myocardial infarction; Relaxin

Indexed keywords

RELAXIN;

ANIMAL; ARTICLE; CELL TRANSPLANTATION; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; MOUSE; MYOBLAST; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; MICE; MYOBLASTS; MYOCARDIUM; PARACRINE COMMUNICATION; RELAXIN; VENTRICULAR REMODELING;

EID: 35649004915     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00115.x     Document Type: Article

References (23)

1. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mensenchymal stem cells. Nat Med. 2005 11 : 367 8.
2. Vandervelde S, van Luyn MJA, Rozenbaum MH, Petersen AH, Tio RA, Harmsen MC. Stem cell-related cardiac gene expression early after murine myocar-dial infarction. Cardiovasc Res. 2007 73 : 783 93.
3. Lu H, Xu X, Zhang M, Cao R, Bråkenhielm E, Li C, Lin H, Yao G, Sun H, Qi L, Tang M, Dai H, Zhang Y, Su R, Bi Y, Zhang Y, Cao Y. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci USA. 2007 104 : 12140 5.
4. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li RK, Steinhoff G. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007 25 : 2118 27.
5. Urbanek K, Rota M, Cascapera S, Bearzi C, Nascimbene A, De Angelis A, Hosoda T, Chimenti S, Baker M, Limana F, Murzynska D, Torella D, Rotatori F, Msso E, Quaini F, Leri A, Kajstura J, Anversa P. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005 97 : 663 73.
6. Kanellakis P, Slater NJ, Du XJ, Bobik A, Curtis DJ. Granulocyte colony-stimulating factor and stem cell factor improves endogenous repair after myocardial infarction. Cardiovasc Res. 2006 70 : 117 25.
7. Lu L, Zhang JQ, Ramires FJ, Sun Y. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun. 2004 320 : 907 13.
8. Xu R, Chen J, Cong X, Hu S, Chen X. Lovastatin protects mesenchymal stem cells against hypoxia-and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. J Cell Biochem. 2007.
9. Formigli L, Perna AM, Meacci E, Cinci L, Margheri M, Nistri S, Tani A, Silvertown J, Orlandini G, Porciani C, Zecchi-Orlandini S, Medin J, Bani D. Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling. J Cell Mol Med. 2007 11 : 1086 99.
10. Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C, Sorg RV, Kögler G, Wernet P, Müller HW, Köstering M. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol. 2005 46 : 1651 8.
11. Samuel CS, Du XJ, Bathgate RAD, Summers RJ. "Relaxin" the stiffened heart and arteries:The therapeutic potential for relaxin in cardiovascular disease. Pharmacol Ther. 2006 112 : 529 52.
12. Samuel CS, Unemori EN, Mookerjee I, Bathgate RAD, Layfield SL, Mak J, Tregear GW, Du XJ. Relaxin modulates cardiac fibroblast proliferation and collagen production and reverses cardiac fibrosis in vivo. Endocrinology. 2004 145 : 4125 33.
13. Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Ross A.D, Bathgate RAD, Du XJ, Samuel CS. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension. 2005 46 : 412 8.
14. Perna AM, Masini E, Nistri S, Briganti V, Chiappini L, Stefano P, Bigazzi M, Pieroni C, Bani Sacchi T, Bani D. Novel drug development opportunity for relaxin in acute myocardial infarction:evidences from a swine model. FASEB J. 2005 19 : 1525 7.
15. Moore XL, Tan SL, Lo CY, Fang L, Su Y, Gao XM, Woodcock EA, Summers RJ, Tregear GW, Bathgate RAD, Du XJ. Relaxin antagonizes hyper-trophy and apoptosis in neonatal rat cardiomyocytes. Endocrinology. 2007 148 : 1582 9.
16. Conrad KP, Novak J. Emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol. 2004 287 : R250 61.
17. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 2000 8 : 361 70.
18. Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer. 2006 118 : 62 73.
19. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 53 : 31 47.
20. Niagara MI, Haider HK, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res. 2007 100 : 545 55.
21. Formigli L, Francini F, Tani A, Squecco R, Nosi D, Polidori L, Nistri S, Chiappini L, Cesati V, Pacini A, Perna AM, Orlandini GE, Zecchi Orlandini S, Bani D. Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favoured by direct cell-cell contacts and relaxin treatment. Am J Physiol Cell Physiol. 2005 288 : C795 804.
22. Mazhari R, Hare JM. Mechanisms of action of mes-enchymal stem cells in cardiac repair:potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007 4 : S21 6.
23. Ohleth KM, Lenhart JA, Ryan PL, Radecki SV, Bagnell CA. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology. 1997 123 : 3652 8.